Spruce Biosciences, Inc. Capital Expenditures Incurred but Not yet Paid
Spruce Biosciences, Inc. (SPRB) reported Capital Expenditures Incurred but Not yet Paid of $14.00 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Cash Flow
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2021-11-15
- Spruce Biosciences, Inc. capital expenditures incurred but not yet paid for the quarter ending 2020-09-30 was -$16.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month |
|---|---|---|---|
| 2020-09-30 | -$16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $14.00K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $30.00K 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |